ESC 365 - Clonal hematopoiesis- An emerging risk modifier in atherosclerosis?

Open Access

Clonal hematopoiesis- An emerging risk modifier in atherosclerosis?

Session: Tackling the inflammatory side of atherosclerosis.

Topic: Vascular Diseases

Speaker: Assistant Professor J. Fuster (Madrid, ES)

Event: ESC CONGRESS 2019

Congress Session

About the speaker

Assistant Professor Jose Javier Fuster

Spanish National Centre for Cardiovascular Research, Madrid (Spain)

3 presentations

1 follower

3 more presentations in this session

Trained immunity to target atherosclerosis.

Speaker: Professor E. Lutgens (Rochester, US)

Immunophenotyping: novel insights from single cell sequencing.

Speaker: Doctor D. Wolf (Freiburg, DE)

Clinical perspective: what can we learn from the CANTOS and CIRT trials

Speaker: Doctor D. Santovito (Munich, DE)

Access the full session

Tackling the inflammatory side of atherosclerosis.

Speakers: Assistant Professor J. Fuster, Professor E. Lutgens, Doctor D. Wolf, Doctor D. Santovito

About the event

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Congress

This platform is supported by